Innovative treatment increases survival of people with malignant...
An innovative treatment significantly increases the survival of people with malignant mesothelioma, a rare but rapidly fatal type of cancer with few effective treatment options, according to results...
View ArticleNew analysis sheds light on cancer incidence and mortality trends in the UK
Trends in cancer incidence and deaths in the United Kingdom (UK) among individuals aged between 35 and 69 years.
View ArticleScientists identify over 5,000 genetic variants that enable certain cancers...
Researchers performed saturation genome editing of the BAP1, whose dysfunction is related to cancer and impaired neurodevelopment.
View ArticleImmunotherapy response assessment in malignant pleural mesothelioma:...
A new research paper was published in Oncotarget's Volume 15 on June 20, 2024, entitled, "Comparison of FDG-PET/CT and CT for evaluation of tumor response to nivolumab plus ipilimumab combination...
View ArticleTriad of immune cells key to successful cancer immunotherapy, study finds
There's a frustrating fact about today's immunotherapies for cancer. While sometimes they work beautifully -; completely eliminating or greatly reducing cancer in particular patients -; other times...
View ArticleFox Chase Cancer Center researchers identify new targets for mesothelioma...
A new research perspective was published in Oncoscience (Volume 11) on May 23, 2024, entitled, "Targeting inflammatory factors for chemoprevention and cancer interception to tackle malignant...
View ArticleAsbestos exposure and carcinogenicity: A comprehensive review
Asbestos, a group of naturally occurring fibrous minerals, has been historically used for its durability and resistance to heat.
View ArticleReview of fasting-mimicking diets in cancer treatment
Researchers present the role of cyclic fasting and fasting-mimicking diets (FMD) in cancer therapy.
View ArticleInsilico Medicine's pan-TEAD inhibitor ISM6331 receives FDA IND clearance for...
Insilico Medicine ("Insilico"), a clinical-stage generative artificial intelligence (AI)-driven biotechnology company, today announced ISM6331, potential best-in-class pan-TEAD inhibitor, has received...
View ArticleEZH2's role in cancer progression and therapy explored
Enhancer of zeste homolog 2 (EZH2) is a catalytic subunit of the Polycomb-repressive complex 2 (PRC2), which plays a crucial role in transcriptional repression through the methylation of histone H3 on...
View ArticleGut bacteria may influence immunotherapy success in mesothelioma patients
A cancer study has found that certain gut bacteria may influence whether or not a patient's immune system is successful in fighting mesothelioma, an aggressive form of cancer.
View ArticleEngineered E. coli shows promise in cancer immunotherapy
Recent research has shown that certain forms of E. coli bacteria tend to colonize hypoxic areas of the body, including tumors, suggesting they might be playing a role in cancer therapeutics.
View ArticleClinical utility of carbonic anhydrase IX in diagnosing pleural mesothelioma
Mesothelioma is an aggressive tumor with a poor prognosis. Histological diagnosis of mesothelioma using limited tissue samples can be challenging.
View ArticleNew biomarkers may offer a more sensitive approach for monitoring kidney health
Drug-induced kidney injury, or nephrotoxicity, is a common complication in clinical medicine that happens when drugs damage the kidneys.
View ArticlePFAS in US water linked to increased cancer risk
A study links PFAS contamination in drinking water to increased cancer risks, highlighting significant impacts on digestive, endocrine, and respiratory systems.
View ArticleInsilico Medicine doses first patient in Phase I Trial of ISM6331 for...
Insilico Medcine( "Insilico") , a clinical stage generative artificial intelligence (AI)-driven biotechnology company today announced the first patient has been dosed in the global multicenter Phase I...
View ArticleFuture of cancer coverage for women federal firefighters uncertain under Trump
It took nearly three years to win presumptive workers' compensation coverage for breast, cervical, and other cancers that firefighters who work for federal agencies may develop because of hazardous...
View ArticleSix promising biomarkers could improve early and accurate detection of kidney...
Critical Path Institute® (C-Path) and Boston Medical Center (BMC) published results for six biomarkers that could improve the early and accurate detection of kidney injury, leading to both the...
View Article